omega-n-methylarginine has been researched along with picibanil in 1 studies
| Studies (omega-n-methylarginine) | Trials (omega-n-methylarginine) | Recent Studies (post-2010) (omega-n-methylarginine) | Studies (picibanil) | Trials (picibanil) | Recent Studies (post-2010) (picibanil) |
|---|---|---|---|---|---|
| 4,411 | 344 | 336 | 1,602 | 149 | 143 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, S; Matsumoto, T; Yamada, H; Yamada, T; Yamashita, U | 1 |
1 other study(ies) available for omega-n-methylarginine and picibanil
| Article | Year |
|---|---|
Enhancing effect of an inhibitor of nitric oxide synthesis on bacillus Calmette-Guerin-induced macrophage cytotoxicity against murine bladder cancer cell line MBT-2 in vitro.
Topics: Animals; Antibodies; Antineoplastic Agents; BCG Vaccine; Cell Communication; Colony-Forming Units Assay; Enzyme Inhibitors; Interferon-gamma; Killer Cells, Natural; Macrophage Activation; Macrophages; Mice; Nitric Oxide; omega-N-Methylarginine; Picibanil; T-Lymphocytes; Thioglycolates; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms | 2000 |